Novo Nordisk eyes Denmark, UK, and Germany for Wegovy pill launch, targeting global weight loss market beyond US dominance.
Bayer posts 9% operating profit jump in Q1, beating expectations. Analysis of how this contrasts with Germany's broader economic slowdown.
Novo Nordisk raises 2026 outlook as Wegovy captures 65% of new US prescriptions, while Pandora faces tariff and silver price pressures.